18 May 2013
Keywords: mylan, orphan, drug, approved, usa, received, approval
Article | 05 September 1994
Mylan has received approval from the US Food and Drug Administration to
market its Cystagon (cysteamine bitartrate) for the 200 or ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
6 February 1995
17 May 2013
© 2013 thepharmaletter.com